These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 27649986)

  • 1. [Cerebrospinal fluid diagnostics in multiple sclerosis].
    Ruprecht K; Tumani H
    Nervenarzt; 2016 Dec; 87(12):1282-1287. PubMed ID: 27649986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update.
    Lo Sasso B; Agnello L; Bivona G; Bellia C; Ciaccio M
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31167509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.
    Gastaldi M; Zardini E; Franciotta D
    Expert Rev Mol Diagn; 2017 Jan; 17(1):31-46. PubMed ID: 27911122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
    Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
    J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.
    Villar LM; Masjuan J; Sádaba MC; González-Porqué P; Plaza J; Bootello A; Alvarez-Cermeño JC
    Arch Neurol; 2005 Apr; 62(4):574-7. PubMed ID: 15824255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research approaches on the diagnosis of multiple sclerosis by CSF examination.
    Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
    Schweiz Arch Neurol Psychiatr (1985); 1987; 138(3):13-22. PubMed ID: 2441464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological diagnostic criteria in multiple sclerosis].
    Dimitri D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):968-73. PubMed ID: 11787362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrospinal fluid in multiple sclerosis].
    Mitsui T; Ohno R
    Nihon Rinsho; 2003 Aug; 61(8):1335-9. PubMed ID: 12962020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
    Nemecek A; Zimmermann H; Rübenthaler J; Fleischer V; Paterka M; Luessi F; Müller-Forell W; Zipp F; Siffrin V
    Mult Scler; 2016 Apr; 22(4):483-93. PubMed ID: 26163073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of biology to diagnosis of multiple sclerosis].
    Liblau R
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):963-7. PubMed ID: 11787361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid analysis.
    Giovannoni G
    Handb Clin Neurol; 2014; 122():681-702. PubMed ID: 24507540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cerebrospinal Fluid in Multiple Sclerosis.
    Deisenhammer F; Zetterberg H; Fitzner B; Zettl UK
    Front Immunol; 2019; 10():726. PubMed ID: 31031747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrophoretic demonstration of unique oligoclonal immunoglobulins in cerebrospinal fluid as a diagnostic test for multiple sclerosis.
    Casey BR; Wong ST; Mason AJ; Lee R; Ford HC
    Clin Chim Acta; 1981 Aug; 114(2-3):187-94. PubMed ID: 7285345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
    Stangel M; Fredrikson S; Meinl E; Petzold A; Stüve O; Tumani H
    Nat Rev Neurol; 2013 May; 9(5):267-76. PubMed ID: 23528543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid analysis in multiple sclerosis.
    Luque FA; Jaffe SL
    Int Rev Neurobiol; 2007; 79():341-56. PubMed ID: 17531849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.